Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01704209 · ClinicalTrials.gov registry record · Phase 1
Collagen Injections for the Treatment of Acne Scars and Wrinkles
A Phase 1 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01704209 is a Phase 1 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 4 participants.
The verdict
NCT01704209, a Phase 1 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if autologous (your own) fibroblast injections are effective for the treatment of acne scars and wrinkles.
Interventions
- DRUG Fibroblast Treatment
- PROCEDURE Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01704209
The ClinicalTrials.gov registry entry for NCT01704209 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fibroblast Treatment is the first listed.
NCT01704209 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01704209 about?
NCT01704209 is a clinical study titled "Collagen Injections for the Treatment of Acne Scars and Wrinkles". The purpose of this study is to find out if autologous (your own) fibroblast injections are effective for the treatment of acne scars and wrinkles.
What is the current status of trial NCT01704209?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2013-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01704209?
The interventions under investigation include: Fibroblast Treatment (DRUG), Vehicle (PROCEDURE).
Who is sponsoring clinical trial NCT01704209?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.